| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2174/092986708784567680 |
| P698 | PubMed publication ID | 18537616 |
| P2093 | author name string | GuoGang Tu | |
| HuiMing Huang | |||
| ShaoHua Li | |||
| WenFang Xu | |||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1388-1395 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Current Medicinal Chemistry | Q3007710 |
| P1476 | title | Progress in the development of matrix metalloproteinase inhibitors | |
| P478 | volume | 15 |
| Q41843257 | A QSAR Study of Matrix Metalloproteinases Type 2 (MMP-2) Inhibitors with Cinnamoyl Pyrrolidine Derivatives |
| Q37745603 | Activation of fibroblasts in cancer stroma |
| Q38871811 | An update on the up and coming therapies to treat osteoarthritis, a multifaceted disease. |
| Q35821610 | Biologic basis of osteoarthritis: state of the evidence |
| Q39516147 | Biphenyl sulfonylamino methyl bisphosphonic acids as inhibitors of matrix metalloproteinases and bone resorption |
| Q27022816 | Cancer-associated fibroblasts in digestive tumors |
| Q45766467 | Chemical-physical analysis of a tartrate model compound for TACE inhibition. |
| Q85118706 | Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer |
| Q34585357 | Comparative serum proteome expression of the steroid-induced femoral head osteonecrosis in adults |
| Q51097569 | Computational Approaches to Matrix Metalloprotease Drug Design. |
| Q42419112 | Doxycycline inhibits leukemic cell migration via inhibition of matrix metalloproteinases and phosphorylation of focal adhesion kinase |
| Q36130989 | Evaluation of Effective MMP Inhibitors from Eight Different Brown Algae in Human Fibrosarcoma HT1080 Cells |
| Q34705367 | Expression of matrix metalloproteinase-12 in aortic dissection |
| Q33887938 | Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain |
| Q33555398 | High expression of osteoglycin decreases gelatinase activity of murine hepatocarcinoma Hca-F cells |
| Q44227577 | Human macrophage metalloelastase correlates with angiogenesis and prognosis of gastric carcinoma |
| Q38014073 | Hydroxamic acids as matrix metalloproteinase inhibitors |
| Q33939916 | Identification of novel matrix metalloproteinase inhibitors by screening of phenol fragments library. |
| Q38259533 | Impact of proteolytic enzymes in colorectal cancer development and progression |
| Q46231247 | In Silico prediction of the molecular basis of ClTx and AaCTx interaction with matrix metalloproteinase-2 (MMP-2) to inhibit glioma cell invasion. |
| Q36787079 | Inhibition of MMP-2 and MMP-9 Activities by Limonium tetragonum Extract |
| Q39792473 | Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3. |
| Q27664274 | Insights from Selective Non-phosphinic Inhibitors of MMP-12 Tailored to Fit with an S1' Loop Canonical Conformation |
| Q39710022 | Liposome-mediated amplified detection of cell-secreted matrix metalloproteinase-9. |
| Q37333777 | Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection |
| Q37024770 | Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core |
| Q91259885 | Matrix metalloproteinases in pro-atherosclerotic arterial remodeling |
| Q43199678 | Microwave-assisted synthesis of triple-helical, collagen-mimetic lipopeptides |
| Q39667155 | Novel yeast bioassay for high-throughput screening of matrix metalloproteinase inhibitors |
| Q37809746 | Pharmacologic therapy for osteoarthritis—the era of disease modification |
| Q47394596 | Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer |
| Q30654110 | Self-assembling gradient copolymers of vinylimidazol and (acrylic)ibuprofen with anti-inflammatory and zinc chelating properties |
| Q27681108 | Simple Pseudo-dipeptides with a P2' Glutamate: A NOVEL INHIBITOR FAMILY OF MATRIX METALLOPROTEASES AND OTHER METZINCINS |
| Q33598697 | Sulfonate-containing thiiranes as selective gelatinase inhibitors |
| Q39640796 | Suppression on metastasis by rhubarb through modulation on MMP-2 and uPA in human A549 lung adenocarcinoma: An ex vivo approach |
| Q51830769 | Synthesis, SAR, and biological evaluation of alpha-sulfonylphosphonic acids as selective matrix metalloproteinase inhibitors. |
| Q39573243 | Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12. |
| Q37346515 | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance |
| Q27004958 | The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer |
| Q51012146 | The conformational landscape of tartrate-based inhibitors of the TACE enzyme as revealed by Hamiltonian Replica Exchange simulation. |
| Q41544769 | Understanding the binding of inhibitors of matrix metalloproteinases by molecular docking, quantum mechanical calculations, molecular dynamics simulations, and a MMGBSA/MMBappl study |
Search more.